Thyrocare Technologies Limited (NSE:THYROCARE) — Market Cap & Net Worth
Market Cap & Net Worth: Thyrocare Technologies Limited (THYROCARE)
Thyrocare Technologies Limited (NSE:THYROCARE) has a market capitalization of $918.47 Million (Rs84.93 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #9472 globally and #461 in its home market, demonstrating a -1.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Thyrocare Technologies Limited's stock price Rs533.60 by its total outstanding shares 159161691 (159.16 Million). Review Thyrocare Technologies Limited debt and liabilities to assess the company's total debt and financial obligations.
Thyrocare Technologies Limited Market Cap History: 2016 to 2026
Thyrocare Technologies Limited's market capitalization history from 2016 to 2026. Data shows growth from $996.27 Million to $918.47 Million (0.36% CAGR).
Index Memberships
Thyrocare Technologies Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$147.46 Billion | 0.62% | #56 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.03% | #381 of 750 |
Weight: Thyrocare Technologies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Thyrocare Technologies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Thyrocare Technologies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Thyrocare Technologies Limited's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.56x
Thyrocare Technologies Limited's market cap is 0.56 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.02 Billion | $3.07 Billion | $709.65 Million | 0.33x | 1.44x |
| 2018 | $798.68 Million | $3.56 Billion | $932.75 Million | 0.22x | 0.86x |
| 2019 | $856.93 Million | $4.03 Billion | $851.40 Million | 0.21x | 1.01x |
| 2020 | $1.44 Billion | $4.33 Billion | $884.00 Million | 0.33x | 1.63x |
| 2021 | $1.77 Billion | $4.95 Billion | $1.13 Billion | 0.36x | 1.56x |
| 2022 | $1.01 Billion | $5.89 Billion | $1.76 Billion | 0.17x | 0.57x |
| 2023 | $1.09 Billion | $5.27 Billion | $644.90 Million | 0.21x | 1.68x |
| 2024 | $1.57 Billion | $5.72 Billion | $707.60 Million | 0.27x | 2.22x |
| 2025 | $767.17 Million | $6.87 Billion | $915.10 Million | 0.11x | 0.84x |
| 2026 | $918.47 Million | $8.29 Billion | $1.63 Billion | 0.11x | 0.56x |
Competitor Companies of THYROCARE by Market Capitalization
Companies near Thyrocare Technologies Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Thyrocare Technologies Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Thyrocare Technologies Limited Historical Marketcap From 2016 to 2026
Between 2016 and today, Thyrocare Technologies Limited's market cap moved from $996.27 Million to $ 918.47 Million, with a yearly change of 0.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs918.47 Million | +19.72% |
| 2025 | Rs767.17 Million | -51.12% |
| 2024 | Rs1.57 Billion | +44.64% |
| 2023 | Rs1.09 Billion | +7.87% |
| 2022 | Rs1.01 Billion | -43.02% |
| 2021 | Rs1.77 Billion | +22.73% |
| 2020 | Rs1.44 Billion | +67.87% |
| 2019 | Rs856.93 Million | +7.29% |
| 2018 | Rs798.68 Million | -21.60% |
| 2017 | Rs1.02 Billion | +2.25% |
| 2016 | Rs996.27 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Thyrocare Technologies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $918.47 Million USD |
| MoneyControl | $918.47 Million USD |
| MarketWatch | $918.47 Million USD |
| marketcap.company | $918.47 Million USD |
| Reuters | $918.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more